Predicting the Malignant Transformation of Oral Submucous Fibrosis Using Quantitative Biomarkers p63 and CD31

Introduction: Oral submucous fibrosis (OSMF) is a pre-malignant condition highly prevalent in India with a malignant transformation rate of 2–8%. Its incidence amongst younger population has risen due to increased consumption of commercial preparations of areca. p63, a homolog of p53, has a role in...

Full description

Bibliographic Details
Main Authors: Radhika Manoj Bavle, Konda Paremala, Makarala Sowmya, Muniswamappa Sudhakara, Venugopal Reshma, Sreelatha Hosthor
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Journal of Orofacial Sciences
Subjects:
p63
Online Access:http://www.jofs.in/article.asp?issn=0975-8844;year=2020;volume=12;issue=1;spage=52;epage=60;aulast=Bavle
id doaj-561a16084ae24907ba000b9634bc8667
record_format Article
spelling doaj-561a16084ae24907ba000b9634bc86672020-11-25T02:38:10ZengWolters Kluwer Medknow PublicationsJournal of Orofacial Sciences0975-88442020-01-01121526010.4103/jofs.jofs_6_20Predicting the Malignant Transformation of Oral Submucous Fibrosis Using Quantitative Biomarkers p63 and CD31Radhika Manoj BavleKonda ParemalaMakarala SowmyaMuniswamappa SudhakaraVenugopal ReshmaSreelatha HosthorIntroduction: Oral submucous fibrosis (OSMF) is a pre-malignant condition highly prevalent in India with a malignant transformation rate of 2–8%. Its incidence amongst younger population has risen due to increased consumption of commercial preparations of areca. p63, a homolog of p53, has a role in epithelial proliferation and is frequently altered in dysplasia and associated with tumorigenesis. CD31 is a highly specific endothelial marker with varied expression in epithelial dysplasia and carcinoma. Epithelial proliferation and underlying angiogenic support are vital processes for malignant transformation. Therefore the present study aims to determine if p63 and CD31 expression is associated with increased malignant transformation of OSMF. Materials and Methods: A cross-sectional study wherein n = 36 OSMF samples were histologically graded into Group I (Early-Ea), II (Moderately advanced-MA) and III (Advanced-Ad) and analysed for anti-p63 and anti-CD31 antibodies. The expression was evaluated quantitatively and by pattern of distribution across the groups and statistically analysed with Chi-Square and Kruskal-Wallis tests (SPSS v2.0). Results: p63 expression of epithelium in Group I ∼100% (basal, suprabasal), II − 60.9% (basal, spinous), III − 62.5% (basal, spinous, granular) with a significant P-value < 0.001FNx01. Predominant pattern of CD31 positive vessels in Group I ∼60% (constricted), II > 50% (normal diameter) and III ∼ 75% (dilated) with a significant P-value of 0.02FNx01. Conclusion: A significant linear increase in nuclear staining of p63 and involvement of epithelial strata observed from Ea → MA → Ad grade of OSMF. CD31 expression exhibited more dilated vessels as OSMF grade increased from Ea → Ad. Therefore p63 and CD31 could be used as quantitative predictive biomarkers of malignant transformation of OSMF.http://www.jofs.in/article.asp?issn=0975-8844;year=2020;volume=12;issue=1;spage=52;epage=60;aulast=Bavlecd31oral submucous fibrosisp63quantitative biomarkersmalignant transformation
collection DOAJ
language English
format Article
sources DOAJ
author Radhika Manoj Bavle
Konda Paremala
Makarala Sowmya
Muniswamappa Sudhakara
Venugopal Reshma
Sreelatha Hosthor
spellingShingle Radhika Manoj Bavle
Konda Paremala
Makarala Sowmya
Muniswamappa Sudhakara
Venugopal Reshma
Sreelatha Hosthor
Predicting the Malignant Transformation of Oral Submucous Fibrosis Using Quantitative Biomarkers p63 and CD31
Journal of Orofacial Sciences
cd31
oral submucous fibrosis
p63
quantitative biomarkers
malignant transformation
author_facet Radhika Manoj Bavle
Konda Paremala
Makarala Sowmya
Muniswamappa Sudhakara
Venugopal Reshma
Sreelatha Hosthor
author_sort Radhika Manoj Bavle
title Predicting the Malignant Transformation of Oral Submucous Fibrosis Using Quantitative Biomarkers p63 and CD31
title_short Predicting the Malignant Transformation of Oral Submucous Fibrosis Using Quantitative Biomarkers p63 and CD31
title_full Predicting the Malignant Transformation of Oral Submucous Fibrosis Using Quantitative Biomarkers p63 and CD31
title_fullStr Predicting the Malignant Transformation of Oral Submucous Fibrosis Using Quantitative Biomarkers p63 and CD31
title_full_unstemmed Predicting the Malignant Transformation of Oral Submucous Fibrosis Using Quantitative Biomarkers p63 and CD31
title_sort predicting the malignant transformation of oral submucous fibrosis using quantitative biomarkers p63 and cd31
publisher Wolters Kluwer Medknow Publications
series Journal of Orofacial Sciences
issn 0975-8844
publishDate 2020-01-01
description Introduction: Oral submucous fibrosis (OSMF) is a pre-malignant condition highly prevalent in India with a malignant transformation rate of 2–8%. Its incidence amongst younger population has risen due to increased consumption of commercial preparations of areca. p63, a homolog of p53, has a role in epithelial proliferation and is frequently altered in dysplasia and associated with tumorigenesis. CD31 is a highly specific endothelial marker with varied expression in epithelial dysplasia and carcinoma. Epithelial proliferation and underlying angiogenic support are vital processes for malignant transformation. Therefore the present study aims to determine if p63 and CD31 expression is associated with increased malignant transformation of OSMF. Materials and Methods: A cross-sectional study wherein n = 36 OSMF samples were histologically graded into Group I (Early-Ea), II (Moderately advanced-MA) and III (Advanced-Ad) and analysed for anti-p63 and anti-CD31 antibodies. The expression was evaluated quantitatively and by pattern of distribution across the groups and statistically analysed with Chi-Square and Kruskal-Wallis tests (SPSS v2.0). Results: p63 expression of epithelium in Group I ∼100% (basal, suprabasal), II − 60.9% (basal, spinous), III − 62.5% (basal, spinous, granular) with a significant P-value < 0.001FNx01. Predominant pattern of CD31 positive vessels in Group I ∼60% (constricted), II > 50% (normal diameter) and III ∼ 75% (dilated) with a significant P-value of 0.02FNx01. Conclusion: A significant linear increase in nuclear staining of p63 and involvement of epithelial strata observed from Ea → MA → Ad grade of OSMF. CD31 expression exhibited more dilated vessels as OSMF grade increased from Ea → Ad. Therefore p63 and CD31 could be used as quantitative predictive biomarkers of malignant transformation of OSMF.
topic cd31
oral submucous fibrosis
p63
quantitative biomarkers
malignant transformation
url http://www.jofs.in/article.asp?issn=0975-8844;year=2020;volume=12;issue=1;spage=52;epage=60;aulast=Bavle
work_keys_str_mv AT radhikamanojbavle predictingthemalignanttransformationoforalsubmucousfibrosisusingquantitativebiomarkersp63andcd31
AT kondaparemala predictingthemalignanttransformationoforalsubmucousfibrosisusingquantitativebiomarkersp63andcd31
AT makaralasowmya predictingthemalignanttransformationoforalsubmucousfibrosisusingquantitativebiomarkersp63andcd31
AT muniswamappasudhakara predictingthemalignanttransformationoforalsubmucousfibrosisusingquantitativebiomarkersp63andcd31
AT venugopalreshma predictingthemalignanttransformationoforalsubmucousfibrosisusingquantitativebiomarkersp63andcd31
AT sreelathahosthor predictingthemalignanttransformationoforalsubmucousfibrosisusingquantitativebiomarkersp63andcd31
_version_ 1724792371104710656